What caused the after-hours jump in ALSAF.PA stock today?

The after-hours rise to €0.92 was driven by higher retail trading and thin liquidity rather than a confirmed earnings update. Volume was **11,506**, above the average of **8,179**, which magnifies price moves in this micro-cap.

Is ALSAF.PA stock a buy after the 19.48% move?

Given negative EPS (**-9,792.48**), weak current ratio (**0.03**) and thin market cap (**€6,842.00**), Meyka AI suggests HOLD. Short-term traders could consider momentum plays, but longer-term buyers should wait for clearer financial improvement.

What is the short-term price forecast for ALSAF.PA stock?

Meyka AI's model projects **€1.06** in one month, implying **+15.22%** from the current **€0.92** price. Forecasts are model-based projections and not guarantees.

Which metrics should I watch next for ALSAF.PA stock?

Monitor daily traded volume versus average **8,179**, cash per share figures, any contract or regulatory news on SteriSpine products, and short-term technicals like RSI and ADX to confirm momentum.

EU Stocks

ALSAF.PA Safe Orthopaedics EURONEXT +19.48% A/H 17 Feb 2026: volume spike

ByDanny Kontos February 17, 2026

The ALSAF.PA stock moved sharply in after-hours trading on 17 Feb 2026, rising to €0.92, a +19.48% intraday gain on 11,506 shares traded. This high-volume mover flags renewed trader interest in Safe Orthopaedics SA on EURONEXT and demands a quick read of liquidity, capital structure and technical signals before positioning. We summarise the drivers, financial red flags and short-term forecasts so investors can assess risk versus reward in this micro-cap healthcare name.